Final report for MicroActive has been published
The MicroActive project has developed an instrument for molecular diagnostics intended for use in the doctors’ office. The instrument will first be used for patient screening for a group of viruses causing cervical cancer. Microfluidics and biotechnology form the basis for the development.
BioFluidix is contributing to this project through its PipeJet® printing technology and microfluidic design experience.